中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Integrative Proteomics and Histone PTMomics Study on Anti-TNBC Effect of JIB-04

文献类型:期刊论文

作者Tao, Shengna6,7; Guo, Jingli5,6; Zhang, Jingdan3,4; Zhang, Mingya6; Wang, Zhe2; Zhang, Jun5,6; Li, Mingjun1; Liu, Bin7; Yuan, Jian2; Tan, Minjia3,4,5,6
刊名JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
出版日期2025-07-02
页码12
关键词Proteomics histone PTMomics epigenetic inhibitor JIB-04 TNBC
ISSN号1044-0305
DOI10.1021/jasms.5c00022
英文摘要The incidence of malignant breast cancer is increasing, and triple-negative breast cancer (TNBC) is particularly challenging due to its poor prognosis and limited response to conventional treatments. Recently, epigenetic inhibitors have emerged as promising therapeutic strategies for TNBC. JIB-04, that targeted histone lysine demethylases (KDMs), was reported to show anticancer activities against TNBC. However, the molecular mechanism underlying the antitumor effect of JIB-04 remains elusive. Herein, we integrated histone PTMomics and quantitative proteomics to comprehensively characterize histone PTM site changes and signaling pathway alterations. Under JIB-04 treatment, a total of 14 significantly altered histone PTM sites were identified, including previously reported sites (H3K9me2, H3K9me3, and H3K36me3) and two newly reported sites (H3K79me2 and H3K9ac). Proteomic analysis quantified 904 differentially expressed proteins, including 495 upregulated and 409 downregulated proteins. Pathway enrichment analysis suggested that JIB-04 significantly affected the DNA damage response. Further biological evidence demonstrated that JIB-04 modulated DNA damage response, cell cycle arrest, and apoptosis. In summary, our study provides new mechanistic insights into the anticancer activity of JIB-04 and offers new options for the treatment of TNBC.
WOS关键词CANCER ; PHOSPHORYLATION ; CHALLENGES ; THERAPY ; SUV39H2 ; CELLS
资助项目National Natural Science Foundation of China[2024YFC2815903] ; National Key R&D Program of China[22XD1420900] ; Program of Shanghai Academic Research Leader[32090032] ; National Natural Science Foundation of China
WOS研究方向Biochemistry & Molecular Biology ; Chemistry ; Spectroscopy
语种英语
WOS记录号WOS:001521559600001
出版者AMER CHEMICAL SOC
源URL[http://119.78.100.183/handle/2S10ELR8/318678]  
专题新药研究国家重点实验室
通讯作者Tan, Minjia; Zhao, Wensi
作者单位1.Tongji Univ, Shanghai Pulm Hosp, Dept Thorac Surg, Sch Med, Shanghai 200433, Peoples R China
2.Tongji Univ, Shanghai East Hosp, State Key Lab Cardiol & Res Ctr Translat Med, Sch Med, Shanghai 200120, Peoples R China
3.Chinese Acad Sci, Zhongshan Inst Drug Discovery, Shanghai Inst Mat Med, Zhongshan 528400, Peoples R China
4.Southern Med Univ, Sch Pharmaceut Sci, Guangzhou 510515, Peoples R China
5.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
6.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
7.Jiangsu Ocean Univ, Coll Pharm, Jiangsu Key Lab Marine Pharmaceut Cpd Screening, Lianyungang 222005, Peoples R China
推荐引用方式
GB/T 7714
Tao, Shengna,Guo, Jingli,Zhang, Jingdan,et al. Integrative Proteomics and Histone PTMomics Study on Anti-TNBC Effect of JIB-04[J]. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY,2025:12.
APA Tao, Shengna.,Guo, Jingli.,Zhang, Jingdan.,Zhang, Mingya.,Wang, Zhe.,...&Zhao, Wensi.(2025).Integrative Proteomics and Histone PTMomics Study on Anti-TNBC Effect of JIB-04.JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY,12.
MLA Tao, Shengna,et al."Integrative Proteomics and Histone PTMomics Study on Anti-TNBC Effect of JIB-04".JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2025):12.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。